2 completed, 1 enrolling by invitation, 1 terminated. 4 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 4 | Completed 2, Enrolling by invitation 1, Terminated 1 |
| Phase 2 | 1 | Completed 1 |
Follow Genital Herpes: new trials by email Literature Review of Genital Herpes trials Research Report on Genital Herpes
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase I Study to Evaluate the Safety, Tolerability, and Immunogenicity of an mRNA Vaccine Against Herpes Simplex Virus Type 2 (HSV-2) Post-Vaccination Low-Dose Cohort, Mid-Dose Cohort, High-Dose Cohort - Genital Herpes | Phase 1 | Enrolling by invitation | Changchun BCHT Biotechnology Co. | 144 | 2025-10-13 | 2026-01-09 |
| A Study of mRNA-1608, a Herpes Simplex Virus -2 (HSV-2) Therapeutic Candidate Vaccine, in Healthy Adults 18 to 55 Years of Age With Recurrent HSV-2 Genital Herpes mRNA-1608, BEXSERO - Genital Herpes | Phase 1 / Phase 2 | Completed | ModernaTX, Inc. | 303 | 2023-09-06 | 2026-05-08 |
| Safety and Efficacy of 4 Investigational HSV 2 Vaccines in Adults With Recurrent Genital Herpes Caused by HSV 2 HSV 2 Formulation 1, HSV 2 Formulation 2, HSV 2 Formulation 3 - Genital Herpes | Phase 1 | Terminated | Sanofi Pasteur, a Sanofi Company | 24 | 2020-02-18 | 2022-10-25 |
| Trial Evaluating Safety, Tolerability and Immune Response of AG-707 AG-707 - Genital Herpes | Phase 1 | Completed | Agenus Inc. | 35 | 2006-03-01 | 2008-10-27 |
Herpes Genitalis (4)
Communicable Diseases (4) · DNA Virus Infections (4) · Female Urogenital Diseases (4) · Female Urogenital Diseases and Pregnancy Complications (4) · Genital Diseases (4) · Genital Diseases, Female (4) · Genital Diseases, Male (4) · Herpes Simplex (4) · Herpesviridae Infections (4) · Infections (4) · Male Urogenital Diseases (4) · Sexually Transmitted Diseases (4) · Sexually Transmitted Diseases, Viral (4) · Urogenital Diseases (4) · Virus Diseases (4)
4CMenB vaccine (1) · Cohort Studies (1) · Sodium Chloride (1)
Agenus Inc. (1) · Changchun BCHT Biotechnology Co. (1) · ModernaTX, Inc. (1) · Sanofi Pasteur, a Sanofi Company (1)
United States (3) · China (1)